blueharbor bank Reports Second Quarter 2025 Net Income
blueharbor bank Reports Second Quarter 2025 Net Income |
[17-July-2025] |
MOORESVILLE, N.C., July 17, 2025 /PRNewswire/ -- blueharbor bank (the "Bank") today reported earnings for the second quarter of 2025. Second Quarter 2025 Highlights
blueharbor bank reported net income of $2,512,699 and $0.83 per diluted share for the second quarter of 2025, an increase of 76%, or $1,083,111, as compared to $1,429,588 and $0.47 per diluted share for the second quarter of 2024. For the six months ended June 30, 2025, the Bank reported net income of $4,905,646 and $1.63 per diluted share compared to $2,766,196 and $0.92 per diluted share for the same six months in 2024. The Bank reported total assets of $544.3 million at June 30, 2025, an increase of $37.6 million, or 7%, when compared to $506.8 million at December 31, 2024, and an increase of $81.0 million, or 18%, when compared to June 30, 2024. Gross loans increased $29.4 million, to $462.1 million at June 30, 2025, from $432.8 million at December 31, 2024. When compared to June 30, 2024, gross loans increased $70.8 million, or 18%. Total deposits were $468.1 million at June 30, 2025, an increase of $27.4 million, or 6%, when compared to $440.7 million at December 31, 2024, and an increase of $63.7 million, or 16% when compared to June 30, 2024. Asset quality remained very strong for the second quarter of 2025, with zero non-performing assets, which is down from 0.01% reported at June 30, 2024. Capital levels also remained high with total risk-based capital at 14.1%, both common equity tier 1 and tier 1 to risk-weighted assets of 13.1%, and tier 1 leverage ratio of 12.0% for the quarter ended June 30, 2025. Net interest income was $5,276,207 for the quarter ending June 30, 2025, an increase of $1,068,699, or 25%, from the same period in 2024. The change in net interest income was driven by a $59.7 million increase in average loans outstanding, an 18 basis point increase in the yield on earning assets, and a 22 basis point decrease in cost of funds. The bank recorded a quarterly provision for credit losses of $236,769 for the first quarter of 2025, compared to a quarterly provision for credit losses of $232,541 for the same period in 2024. The allowance for loan losses to total loans was 0.95% at June 30, 2025. Noninterest income was $572,860 for the quarter ended June 30, 2025, a $49,696, or 9%, increase over the $523,164 that was recorded for the quarter ended June 30, 2024. The increase was due partially to the higher service charge fees and debit card income from the increase in the number of deposit accounts over the period. Another factor contributing to the change was an increase in mortgage loan fees. Noninterest expense was $2,375,524 for the quarter ended June 30, 2025, compared to $2,663,598 for the quarter ended June 30, 2024. The decrease of $288,074 was due to lower data processing expenses from the change in our core software provider in May 2024. Jim Marshall, President and Chief Executive Officer, commented, "We are very proud and pleased with our solid performance for the quarter and first half of 2025. I would like to commend our team for the outstanding deep relationships they have developed with our customers, and to our customers that continually refer their friends to us because of the level of service and professionalism they receive here at blueharbor." blueharbor bank is headquartered in Mooresville with branches in Statesville and Mount Airy and loan production offices in Belmont and Hickory. blueharbor bank's website is www.blueharborbank.com and our common stock is quoted on the OTCQX Market under the symbol "BLHK." Summary Selected Financial Data Schedule attached below. Forward-Looking Statement:
SOURCE blueharbor bank | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Codes: OTC-BB:BLHK, OTC-PINK:BLHK, OTC-QX:BLHK |